Te­va tri­al over al­leged Medicare kick­backs stopped while pend­ing ap­peal of po­ten­tial $10B judg­ment

Last year
Pharma
Law

An­oth­er Eylea com­peti­tor pre­pares to en­ter the ring fol­low­ing pos­i­tive PhI­II read­out

Last year
Pharma
FDA+

Ra­dio­phar­ma­ceu­ti­cal biotech Ra­dio­net­ics in fundrais­ing mode with $54.2M so far

Last year
Financing

Q&A: FDA's Pe­ter Marks ready to en­cour­age more ac­cel­er­at­ed ap­provals for rare dis­eases

Last year
People
FDA+

Leg­end im­proves ac­cess to Carvyk­ti, but cell ther­a­py lags de­mand as biotech seeks ear­li­er-line ap­proval

Last year
Pharma
Cell/Gene Tx

Pre­ci­sion Bio­Sciences hands glob­al rights to CAR-T can­di­date; Sagimet clos­es un­der­writer’s op­tion to buy stock

Last year
News Briefing

Tetra Pharm opens new head­quar­ters to boost cannabi­noid drug re­search and man­u­fac­tur­ing

Last year
Pharma
Manufacturing

Day One Bio­phar­ma­ceu­ti­cals inks re­search col­lab­o­ra­tion with Swedish biotech

Last year
Deals
R&D

Sanofi bid first, but Bio­gen won out in fight to ac­quire Rea­ta — re­port 

Last year
Pharma

Im­pel Phar­ma con­sid­ers bank­rupt­cy, as­set sales de­spite mi­graine nasal spray quar­ter­ly rev­enue jump

Last year
R&D

Medi­Wound’s US launch of its top­i­cal gel for burns de­layed to Q1 due to man­u­fac­tur­ing ‘de­vi­a­tion’

Last year
Pharma

Ama­zon Phar­ma­cy de­liv­ers in­sulin dis­counts in new au­to­mat­ic coupon pro­gram

Last year
Pharma

FDA fi­nal­izes 2014 guid­ance on in­formed con­sent in tri­als, with more up­dates com­ing soon

Last year
FDA+

Bio­con fa­cil­i­ty in Malaysia found to have is­sues once again by the FDA

Last year
Pharma
FDA+

Bris­tol My­ers to cut 108 em­ploy­ees in New Jer­sey

Last year
People
Pharma

FDA pro­mo­tions watch­dog de­liv­ers first warn­ing let­ter of the year to As­traZeneca over Breztri mar­ket­ing

Last year
Pharma
FDA+

Am­i­cus scores an­oth­er ap­proval in the UK for Pompe dis­ease ther­a­py, ex­pects FDA OK in Q3

Last year
Pharma

Mar­ket­ingRx roundup: Pfiz­er teams with Food Net­work star; Bris­tol My­ers earns 'bil­lion dol­lar' dis­tinc­tion

Last year
Pharma
Marketing

How Ex­act Sci­ences' out-of-the-box think­ing con­vinced Amer­i­cans to try Co­lo­guard's col­orec­tal can­cer screen­ing test

Last year
Pharma
Marketing

Galec­to ax­es lead can­di­date in lung dis­ease af­ter PhI­Ib miss, stock craters

Last year
R&D

Sino­vac's Covid vac­cine sales nose­dive; Gra­cell trims pipeline, starts lu­pus study

Last year
News Briefing

Gilead dish­es out $66M for San Diego biotech's 'ten­ta­cles' in can­cer, in­flam­ma­tion

Last year
Startups
Deals

Ger­man gener­ic drug com­pa­ny Sta­da in ear­ly talks over pos­si­ble $11B sale, ex­ec con­firms

Last year
Deals

FDA lifts par­tial hold on Ar­cel­lx’s Gilead-part­nered blood can­cer cell ther­a­py as biotech aims for 2026 launch

Last year
R&D
Cell/Gene Tx
First page Previous page 295296297298299300301 Next page Last page
A service from the Financial Times